Virpax PharmaceuticalsVRPX
13F holders, Q1 2025 (March 31)7holders
1famous investor
$1.20avg. 13F price*
At the end of Q1 2025, 7 institutions reported holding Virpax Pharmaceuticals Inc. (VRPX) in their 13F filings. The largest holders were Millennium Management ($26K), Tower Research Capital LLC (TRC) ($6K) and UBS Group AG ($2K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Virpax Pharmaceuticals Inc.
- CUSIP
- 928251305
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $35K |
| Exits | 0 | $0 |
Ownership 7 holders
| Millennium Management | 0.00% | New | 22,075 | $26K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 4,897 | $6K |
| UBS Group AG | 0.00% | New | 2,000 | $2K |
| SBI Securities Co., Ltd. | 0.00% | New | 108 | $130 |
| Osaic Holdings, Inc. | 0.00% | New | 9 | $10 |
| Bank of America Corp. | 0.00% | New | 5 | $6 |
| Vermillion Wealth Management, Inc. | 0.00% | New | 4 | $5 |
"% of holder's portfolio" is VRPX's weight in each manager's 13F, not the share of Virpax Pharmaceuticals Inc. the manager owns.